California Life Sciences
A public policy research and advocacy organization for California's biomedical industry.
Based in DC
AI Overview
With $1.1M in lobbying spend across 32 quarterly filings, California Life Sciences is a significant lobbying presence. Their lobbying covers 6 issue areas. Active from 2018 to 2025.
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2018 | $120K |
| 2019 | $120K |
| 2020 | $120K |
| 2021 | $120K |
| 2022 | $160K |
| 2023 | $160K |
| 2024 | $160K |
| 2025 | $160K |
Issues Lobbied
Lobbying Firms
Lobbyists
Government Agencies Targeted
These are the government entities that California Life Sciences disclosed contacting in their lobbying filings.
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues, Budget/Appropriations, Medicare/Medicaid, Taxation, Defense and 1 more
Promoted life sciences community and communicated economic and health benefits of the industry.
H.R.1892: Bipartisan Budget Act of 2018 as it relates to a Part D donut hole provision and IPAB repeal.
H.R.1625: Consolidated Appropriations Act, 2018.
H.R.849/H.J.Res 51: IPAB Repeal Act and Joint Resolution related to IPAB Repeal.
H.R. 184: Protect Medical Innovation Act.
FY 2018 Continuing resolution as it relates to suspension of the medical device tax.
H.R.1892: Bipartisan Budget Act of 2018 as it relates to a Part D donut hole provision and IPAB repeal.
Related Analysis
Related Investigations
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.